Clinical Trials in Maryland

Showing 541-560 of 23,284 trials

Recasting or Book Reading by Parents or Clinicians

NCT05099328

Developmental Language Disorder (DLD) affects approximately seven percent of the population and is characterized by grammatical deficits that cascade into lifelong academic challenges and under-employment. Current treatments for DLD produce good outcomes under ideal, high intensity conditions or when parents have been trained to deliver therapy using intense coaching methods; however, current publicly funded service delivery systems and private-pay reimbursement models do not support treatment being delivered in this ideal fashion for children older than three. This project will examine alternative methods of delivering treatment that may be more feasible under typical conditions and will identify implementation barriers, with the goal of improving long-term outcomes for children with DLD. We hypothesize that feasibility and palatability will influence dose, which will in turn affect the overall language outcomes.

Developmental Language Disorder and Language Impairment

University of Delaware137 participantsStarted Sep 2021

Newark, Delaware, United States • College Park, Maryland, United States

RECRUITINGPhase 315 miles

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

NCT06846281

The purpose of this Phase 3b study is to assess the efficacy, safety and tolerability of remibrutinib after switching from ocrelizumab and compared to continuous ocrelizumab treatment, in patients living with relapsing multiple sclerosis (plwRMS).

Relapsing Multiple Sclerosis

Novartis Pharmaceuticals360 participantsStarted Jul 2025

Scottsdale, Arizona, United States • Washington D.C., District of Columbia, United States • Altamonte Springs, Florida, United States +99 more locations

Recasting or Book Reading by Parents or Clinicians

Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.

Find Trials by Condition in Maryland

Long-Term Follow-up of People Undergoing Hematopoietic Stem Cell Transplantation

Natural History of Noncirrhotic Portal Hypertension

Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing

Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy

The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

Testing Dabrafenib and Trametinib With or Without Hydroxychloroquine in Stage IIIC or IV BRAF V600E/K Melanoma

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

An Observational Study to Learn More About How Well a Treatment Works When Given After Treatment With Atezolizumab and Bevacizumab or Another Similar Combination of Drugs in Adults With Liver Cancer That Cannot be Treated With Surgery

The Ailliance Post-Market Clinical Study

Strong Heart Water Study

Management of the PDA Trial

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

A Study Of Multiple Immunotherapy-Based Treatment Combinations In Participants With Metastatic Non-Small Cell Lung Cancer (Morpheus- Non-Small Cell Lung Cancer)

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)